Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers
Chunhong Hu(Central South University), Fang Wu(Central South University), Long Shu(Zhejiang Hospital), Qiongzhi He, Yizheng Li, Zhenhua Qiu(Central South University), Yurong Peng(Central South University), Shenghao Shi(Central South University), Qingchun Liang(Central South University), Yi Jiang(Xinjiang Medical University), Yue Pan(Central South University), Songqing Fan(Central South University), Yue Zeng(The University of Texas MD Anderson Cancer Center), Lishu Zhao(Central South University), Wenliang Liu(Central South University), Chen Chen(Jilin University), Ping Liu(Central South University), Yuxuan Liu(Central South University), Junqi Liu(First Affiliated Hospital of Zhengzhou University), Chao Deng(Central South University), Xiaohan Liu(Central South University), Sujuan Zhang(Capital Medical University), Xianling Liu(Central South University), Yang Shao, Lingling Yang, Danlei Yu(Central South University)
Cited by 77
Related Papers
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
|The Lancet Oncology|2011|4.1k
The biology and role of CD44 in cancer progression: therapeutic implications
|Journal of Hematology & Oncology|2018|1.4k
Clinical Features of the Initial Cases of 2009 Pandemic Influenza A (H1N1) Virus Infection in China
|New England Journal of Medicine|2009|603
Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432
|Annals of Oncology|2019|475
Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis
|Molecular Cancer|2020|465